More: American Glaucoma Society 2008 Annual Meeting

Highlights of the American Glaucoma Society 2008 Annual Meeting CME

March 6 - 9, 2008, Washington DC

Author Information and Disclosures

This activity is not sanctioned by, nor a part of, the American Glaucoma Society 2008 Annual Meeting.

Release Date: April 14, 2008; Valid for credit through April 14, 2009

Credits Available
Physicians - maximum of 0.5 AMA PRA Category 1 Credit(s)™ for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

The materials presented here were prepared by independent authors under the editorial supervision of Medscape and do not represent a publication of the American Glaucoma Society 2008 Annual Meeting. These materials and the related activity are not sanctioned by the American Glaucoma Society 2008 Annual Meeting or the commercial supporter of the conference, and do not constitute an official part of that conference.

Copyright © 2008 Medscape.
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Identify the issues inherent in the underdiagnosis of glaucoma
  2. Explore the extent of exfoliation syndrome and the effect on treatment approaches
  3. Evaluate advances in surgical approaches to glaucoma
  4. Review the risk factors for angle-closure glaucoma
Authors and Disclosures

Ivan Goldberg, MB, BS, FRANZCO, FRACS
Disclosure: Ivan Goldberg, MB, BS, FRANZCO, FRACS, has disclosed that he has received grants for clinical research from Alcon, Allergan, Pfizer, and Novartis. Dr. Goldberg has also disclosed that he has received grants for educational activities from Alcon, Allergan, Ellex, Pfizer, and Merck, and has served as an advisor or consultant to Alcon, Allergan, and Pfizer.


Charlotte Warren
Disclosure: Charlotte Warren has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.